Latest News and Press Releases
Want to stay updated on the latest news?
-
Washington, DC, March 25, 2026 (GLOBE NEWSWIRE) -- ATI Advisory analysis examines 2024 Medicare Shared Savings Program (MSSP) performance data to assess how episode-level spending, post-acute...
-
SAN JOSE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
-
Trial demonstrated no safety concerns when co-administering roluperidone and olanzapine The Company continues to advance the program, with the confirmatory Phase 3 trial now enrolling and topline...
-
Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments
Evaluating Potential to Preserve Muscle Mass Associated with Weight Reduction Announces Preclinical Study Initiation, Patent Filing and Publication of Independent Scientific Research SOLANA BEACH,...
-
SILVER SPRING, MD, March 25, 2026 (GLOBE NEWSWIRE) -- The American Nurses Enterprise (ANE), the unifying force behind the American Nurses Association, the American Nurses Credentialing Center, and the...
-
MONTRÉAL, 25 mars 2026 (GLOBE NEWSWIRE) -- Alors que la Commission de l’économie et du travail poursuit l’étude détaillée du projet de loi 11 (PL11), l’Association pour la santé publique du...
-
The Io Therapeutics, Inc. clinical stage anti-cancer RXR agonist compound demonstrated efficacy in models of human multiple myeloma.
-
Raleigh, NC, March 25, 2026 (GLOBE NEWSWIRE) -- As loneliness increasingly emerges as a major public health concern, a new social platform called Friending aims to help people reconnect in the real...
-
Phase 2b results for GH001 in TRD now published and peer-reviewed in JAMA Psychiatry New peer-reviewed article in forthcoming issue of Psychopharmacology Bulletin demonstrates that GH001 efficacy is...
-
NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- In the wake of a sweeping investigation by CBS News identifying Los Angeles as “ground zero” for hospice fraud, Robin Heffernan, co-founder and CEO of...